Aim: Obesity and excessive abdominal fat accumulation predispose to Metabolic Syndrome (MS). Intermittent fasting (IF) represents a potential dietary approach to reduce its detrimental effects on metabolic and cardiovascular risk. We aimed to investigate the mechanisms involved in the effects of IF.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Atherosclerosis
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
© 2015 Published by Elsevier Inc.